IBER
Ibere Pharmaceuticals
IBER
IBER
Delisted
IBER was delisted on the 1st of March, 2023.
38 hedge funds and large institutions have $71.4M invested in Ibere Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
38
Holding in Top 10
–
Calls
$89K
Puts
–
Top Buyers
| 1 | +$2.46M | |
| 2 | +$2.2M | |
| 3 | +$1.35M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.32M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.31M |
Top Sellers
| 1 | -$151K | |
| 2 | -$46K | |
| 3 | -$4.83K | |
| 4 |
AM
Ampfield Management
New York
|
-$10 |